We are live on
!
Find out more
PC
PA Capital Portfolio holdings
AUM
$142M
1-Year Est. Return
46.45%
This Fund
S&P 500
This Quarter
Est. Return
+1.36%
1 Year Est. Return
+46.45%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$102M
AUM Growth
-$8.37M
(-7.6%)
Cap. Flow
-$6.77M
Cap. Flow
% of AUM
-6.66%
Top 10 Holdings %
Top 10 Hldgs %
27.09%
Holding
141
New
34
Increased
32
Reduced
41
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
uniQure
QURE
|
+$1.16M |
| 2 |
Willis Towers Watson
WTW
|
+$1.11M |
| 3 |
TSG
The Stars Group Inc.
TSG
|
+$993K |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$914K |
| 5 |
PS
Pluralsight, Inc. Class A Common Stock
PS
|
+$906K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Renasant Corp
RNST
|
+$6.61M |
| 2 |
BayCom
BCML
|
+$5.36M |
| 3 |
PRO
PROS Holdings
PRO
|
+$3.01M |
| 4 |
Broadcom
AVGO
|
+$1.2M |
| 5 |
Ball Corp
BALL
|
+$641K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.03% |
| 2 | Communication Services | 17.09% |
| 3 | Healthcare | 14.63% |
| 4 | Industrials | 13.49% |
| 5 | Consumer Discretionary | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Smith & Wesson
SWBI
$651M
| $279K | 0.27% |
61,972
-7,335
| -11% | -$44.2K |
|
102
Electronic Arts
EA
$53B
| $259K | 0.26% |
+2,649
| New | +$249K |
|
103
Aldeyra Therapeutics
ALDX
$92.9M
| $256K | 0.25% |
48,502
+8,232
| +20% | +$44.3K |
|
|
RCM
104
DELISTED
R1 RCM Inc. Common Stock
RCM
| $224K | 0.22% |
+25,101
| New | +$296K |
|
|
EXFO
105
DELISTED
EXFO INC.
EXFO
| $200K | 0.2% |
+50,000
| New | +$189K |
|
|
AUD
106
DELISTED
Audacy, Inc.
AUD
| $179K | 0.18% |
53,702
| – | – |
|
107
Gyre Therapeutics
GYRE
$641M
| $168K | 0.17% |
4,579
+408
| +10% | +$22K |
|
108
OneSpan
OSPN
$574M
| $160K | 0.16% |
11,000
| – | – |
|
|
ARQL
109
DELISTED
Arqule Inc
ARQL
| $160K | 0.16% |
+22,356
| New | +$210K |
|
110
ADMA Biologics
ADMA
$1.96B
| $148K | 0.15% |
33,271
+22,629
| +213% | +$94.6K |
|
111
PUT
Euronet Worldwide
EEFT
$2.72B
| $146K | 0.14% |
+1,000
| New | +$155K |
|
|
CLVS
112
DELISTED
Clovis Oncology, Inc.
CLVS
| $142K | 0.14% |
36,152
+10,437
| +41% | +$84.4K |
|
|
TLGT
113
DELISTED
Teligent, Inc
TLGT
| $141K | 0.14% |
14,840
-2,152
| -13% | -$17K |
|
114
CALL
ADT
ADT
$5.58B
| $104K | 0.1% |
16,600
+5,200
| +46% | +$29.5K |
|
|
TRVG
115
CALL
trivago
TRVG
$373M
| $90K | 0.09% |
+4,360
| New | +$99K |
|
|
MTEM
116
DELISTED
Molecular Templates, Inc.
MTEM
| $89K | 0.09% |
905
+146
| +19% | +$13.6K |
|
117
Acacia Research
ACTG
$428M
| $86K | 0.08% |
32,145
-1,142
| -3% | -$3.19K |
|
|
118
CALL
Smith & Wesson
SWBI
$651M
| $68K | 0.07% |
15,222
| – | – |
|
|
RETA
119
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $64K | 0.06% |
+800
| New | +$67.9K |
|
|
SRRA
120
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $57K | 0.06% |
3,646
-229
| -6% | -$4.38K |
|
121
Apollo Global Management
APO
$72.4B
| – | – |
-18,259
| Closed | -$626K |
|
122
Assembly Biosciences
ASMB
$498M
| – | – |
-960
| Closed | -$155K |
|
|
123
Broadcom
AVGO
$1.85T
| – | – |
-41,760
| Closed | -$1.2M |
|
|
124
Ball Corp
BALL
$17.3B
| – | – |
-9,156
| Closed | -$641K |
|
|
125
BayCom
BCML
$329M
| – | – |
-244,530
| Closed | -$5.36M |
|
Similar funds
AW
CP
DCM
WOA
CFG
BCWM
RIM
SCM
PA Capital's Q3 2019 Portfolio in Review
As of Q3 2019, PA Capital held 141 positions worth $102M, down 7.6% from $110M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
PA Capital withdrew a net $6.77M in Q3 2019, closing 20 positions and reducing 41 holdings. Its most notable exit was Renasant Corp, an estimated $6.61M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, PA Capital opened a new position in uniQure worth $795K.
- PA Capital's largest Q3 2019 buy was uniQure: 20,192 shares worth $795K.
- PA Capital added most to Plantronics, Inc. in Q3 2019, an estimated $563K increase.
- PA Capital's biggest Q3 2019 reduction was BlueLinx, cutting an estimated $597K.
- PA Capital fully exited Renasant Corp in Q3 2019, selling an estimated $6.61M.
- PA Capital's ten largest holdings make up 27% of its $102M portfolio in Q3 2019.
- PA Capital opened 34 new positions and closed 20 in Q3 2019.
- PA Capital's portfolio value fell 7.6% quarter-over-quarter to $102M.
Based on PA Capital's 13F filing for Q3 2019, filed 8 Nov 2019.